Որոնման արդյունքները - Paul M. Beringer
- Ցուցադրվում են 1 - 8 արդյունքները 8
-
1
-
2
Physiologically‐Based Pharmacokinetic‐Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor‐Tezacaftor‐Ivacaftor With Nirmatrelvir‐Ritonavir for the Treatment of COVID‐... Eunjin Hong, Lisa M. Almond, Peter S. Chung, Adupa P. Rao, Paul M. Beringer
Հրապարակվել է 2022Artigo -
3
-
4
-
5
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with... Timothy J. Bensman, Joshua Wang, Jordanna G. Jayne, Lynn Fukushima, Adupa P. Rao, David Z. D’Argenio, Paul M. Beringer
Հրապարակվել է 2017Artigo -
6
Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment Jordanna G. Jayne, Timothy J. Bensman, Justin B. Schaal, A. Young J. Park, Elza Kimura, Dat Q. Tran, Michael E. Selsted, Paul M. Beringer
Հրապարակվել է 2017Artigo -
7
Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series Eunjin Hong, Regina Li, Alan Shi, Lisa M. Almond, Joshua Wang, Amin Z. Khudari, Soumar Haddad, Sarkis Sislyan, Marissa Angelich, Peter S. Chung, Adupa P. Rao, Paul M. Beringer
Հրապարակվել է 2023Artigo -
8
Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation Timothy J. Bensman, Jordanna G. Jayne, Meiling Sun, Elza Kimura, Joshua Meinert, Joshua C. Wang, Justin B. Schaal, Dat Q. Tran, Adupa P. Rao, Omid Akbari, Michael E. Selsted, Paul M. Beringer
Հրապարակվել է 2017Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Internal medicine
Medicine
Biology
Cystic fibrosis
Pharmacology
Bacteria
Genetics
Pharmacokinetics
Immunology
Intensive care medicine
Lung
Cystic fibrosis transmembrane conductance regulator
Environmental health
Inflammation
Ivacaftor
Liter
Nephrotoxicity
Pathology
Pharmacodynamics
Population
Proinflammatory cytokine
Pseudomonas aeruginosa
Sputum
Staphylococcus aureus
Tuberculosis
Vancomycin
Acute kidney injury
Adverse effect
Antibacterial agent
Antibiotics